| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cranial Irradiation | 6 | 2021 | 71 | 1.750 |
Why?
|
| Radiation Exposure | 3 | 2024 | 45 | 1.540 |
Why?
|
| Radiation Injuries, Experimental | 4 | 2017 | 22 | 1.440 |
Why?
|
| Bone Marrow | 3 | 2017 | 317 | 1.280 |
Why?
|
| Glioma | 6 | 2019 | 493 | 1.030 |
Why?
|
| Brain Neoplasms | 10 | 2019 | 1303 | 0.970 |
Why?
|
| Rats | 21 | 2021 | 3374 | 0.910 |
Why?
|
| Leukocytes | 6 | 2024 | 205 | 0.890 |
Why?
|
| Radiation Protection | 3 | 2022 | 50 | 0.830 |
Why?
|
| Brain | 12 | 2021 | 3162 | 0.730 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 49 | 0.660 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2019 | 1110 | 0.640 |
Why?
|
| Radiation Injuries | 2 | 2022 | 141 | 0.630 |
Why?
|
| Animals | 51 | 2026 | 33706 | 0.620 |
Why?
|
| Hematologic Tests | 1 | 2019 | 36 | 0.610 |
Why?
|
| Neurogenesis | 3 | 2022 | 210 | 0.600 |
Why?
|
| Encephalitis | 1 | 2020 | 123 | 0.600 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 80 | 0.590 |
Why?
|
| Multimodal Imaging | 2 | 2017 | 109 | 0.580 |
Why?
|
| Behavior, Animal | 1 | 2020 | 475 | 0.540 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 585 | 0.530 |
Why?
|
| Mannans | 1 | 2017 | 15 | 0.520 |
Why?
|
| Bystander Effect | 1 | 2017 | 5 | 0.520 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 84 | 0.520 |
Why?
|
| Wound Healing | 2 | 2014 | 486 | 0.520 |
Why?
|
| Prebiotics | 1 | 2017 | 29 | 0.510 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2018 | 122 | 0.500 |
Why?
|
| Cell Proliferation | 5 | 2020 | 2460 | 0.500 |
Why?
|
| Microcirculation | 6 | 2006 | 104 | 0.500 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 135 | 0.500 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 75 | 0.490 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 155 | 0.460 |
Why?
|
| Dideoxynucleosides | 1 | 2015 | 9 | 0.460 |
Why?
|
| Machine Learning | 1 | 2019 | 380 | 0.450 |
Why?
|
| Body Weight | 3 | 2016 | 985 | 0.450 |
Why?
|
| Hippocampus | 3 | 2022 | 794 | 0.450 |
Why?
|
| Ferrosoferric Oxide | 1 | 2015 | 25 | 0.450 |
Why?
|
| Blood-Brain Barrier | 5 | 2011 | 152 | 0.450 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4646 | 0.450 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 45 | 0.440 |
Why?
|
| Growth Disorders | 1 | 2016 | 181 | 0.440 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2020 | 637 | 0.430 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 209 | 0.430 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 18 | 0.430 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 399 | 0.430 |
Why?
|
| Allergens | 1 | 2017 | 344 | 0.420 |
Why?
|
| Mice | 28 | 2026 | 18182 | 0.420 |
Why?
|
| Cognition Disorders | 1 | 2018 | 552 | 0.410 |
Why?
|
| Radiation Dosage | 4 | 2024 | 131 | 0.380 |
Why?
|
| Male | 31 | 2024 | 64570 | 0.330 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2009 | 125 | 0.320 |
Why?
|
| Skin Physiological Phenomena | 1 | 2010 | 15 | 0.320 |
Why?
|
| Whole-Body Irradiation | 2 | 2024 | 61 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 4696 | 0.320 |
Why?
|
| Gliosis | 3 | 2020 | 31 | 0.320 |
Why?
|
| Ependymoma | 2 | 2008 | 137 | 0.300 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2009 | 28 | 0.290 |
Why?
|
| Asthma | 1 | 2017 | 920 | 0.290 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 61 | 0.280 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2021 | 255 | 0.270 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 160 | 0.270 |
Why?
|
| Rats, Wistar | 3 | 2017 | 298 | 0.260 |
Why?
|
| Models, Biological | 2 | 2010 | 1375 | 0.260 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 287 | 0.250 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 269 | 0.250 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2026 | 12 | 0.230 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 14 | 0.230 |
Why?
|
| Ellagic Acid | 3 | 2010 | 4 | 0.230 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 123 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2007 | 587 | 0.230 |
Why?
|
| Chitosan | 3 | 2010 | 27 | 0.220 |
Why?
|
| Sirolimus | 1 | 2006 | 230 | 0.220 |
Why?
|
| Adaptive Immunity | 1 | 2026 | 101 | 0.220 |
Why?
|
| Adrenomedullin | 1 | 2025 | 82 | 0.210 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 332 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 679 | 0.210 |
Why?
|
| Blood Cell Count | 1 | 2024 | 65 | 0.200 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 58 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 6175 | 0.200 |
Why?
|
| Oxygen | 2 | 2007 | 548 | 0.200 |
Why?
|
| Cytokines | 2 | 2008 | 1332 | 0.200 |
Why?
|
| Craniotomy | 1 | 2004 | 102 | 0.200 |
Why?
|
| Microscopy | 1 | 2004 | 118 | 0.200 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 133 | 0.190 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 219 | 0.190 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2025 | 222 | 0.180 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.180 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2026 | 280 | 0.180 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 258 | 0.180 |
Why?
|
| Cell Death | 2 | 2020 | 226 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3746 | 0.170 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 279 | 0.170 |
Why?
|
| Astronauts | 1 | 2022 | 81 | 0.170 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2017 | 61 | 0.170 |
Why?
|
| Protons | 1 | 2021 | 94 | 0.170 |
Why?
|
| Neoplasm Transplantation | 3 | 2017 | 358 | 0.170 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2020 | 32 | 0.170 |
Why?
|
| Cyclohexanones | 1 | 2020 | 18 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 33 | 0.160 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 467 | 0.160 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 30 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2020 | 120 | 0.160 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 99 | 0.160 |
Why?
|
| Apoptosis | 3 | 2020 | 1825 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 456 | 0.160 |
Why?
|
| Malignant Hyperthermia | 1 | 2020 | 18 | 0.160 |
Why?
|
| Tumor Microenvironment | 2 | 2026 | 705 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 324 | 0.160 |
Why?
|
| Interferon-beta | 3 | 2010 | 56 | 0.160 |
Why?
|
| Chloride Channels | 1 | 2020 | 55 | 0.160 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 102 | 0.160 |
Why?
|
| Thermogenesis | 1 | 2020 | 57 | 0.160 |
Why?
|
| Metabolic Syndrome | 1 | 2024 | 366 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 981 | 0.150 |
Why?
|
| Random Allocation | 1 | 2020 | 409 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 156 | 0.150 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 167 | 0.150 |
Why?
|
| Animals, Newborn | 2 | 2025 | 1023 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 322 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 226 | 0.150 |
Why?
|
| Pyridines | 1 | 2020 | 256 | 0.150 |
Why?
|
| Space Flight | 1 | 2022 | 176 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2021 | 305 | 0.140 |
Why?
|
| Cell Line, Tumor | 9 | 2026 | 3711 | 0.140 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2020 | 242 | 0.140 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 99 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 229 | 0.130 |
Why?
|
| Radiotherapy Dosage | 2 | 2017 | 217 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2017 | 2 | 0.130 |
Why?
|
| Taurine | 1 | 2017 | 11 | 0.130 |
Why?
|
| Airway Remodeling | 1 | 2017 | 20 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 724 | 0.130 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 27 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 219 | 0.130 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 283 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 2330 | 0.130 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 71 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 136 | 0.130 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 114 | 0.130 |
Why?
|
| Cognition | 3 | 2022 | 822 | 0.130 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 471 | 0.120 |
Why?
|
| Sarcoma, Ewing | 1 | 2018 | 122 | 0.120 |
Why?
|
| Allografts | 1 | 2017 | 220 | 0.120 |
Why?
|
| Venules | 2 | 2013 | 28 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 168 | 0.120 |
Why?
|
| Humans | 27 | 2026 | 130444 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 254 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 780 | 0.120 |
Why?
|
| X-Rays | 1 | 2015 | 29 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1282 | 0.110 |
Why?
|
| Magnetics | 1 | 2015 | 32 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2016 | 68 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 405 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 420 | 0.110 |
Why?
|
| Astrocytes | 2 | 2009 | 265 | 0.110 |
Why?
|
| Algorithms | 3 | 2019 | 1669 | 0.110 |
Why?
|
| Cell Adhesion | 7 | 2011 | 308 | 0.110 |
Why?
|
| Kinetics | 1 | 2017 | 1087 | 0.110 |
Why?
|
| Fasting | 1 | 2016 | 304 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 139 | 0.110 |
Why?
|
| Mesocricetus | 3 | 2003 | 65 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 68 | 0.100 |
Why?
|
| Age Factors | 1 | 2020 | 2822 | 0.100 |
Why?
|
| Quinic Acid | 1 | 2013 | 2 | 0.100 |
Why?
|
| Cricetinae | 3 | 2003 | 361 | 0.100 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 19 | 0.100 |
Why?
|
| Cell Communication | 3 | 2021 | 188 | 0.100 |
Why?
|
| Biopsy | 1 | 2017 | 1240 | 0.100 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 54 | 0.100 |
Why?
|
| Inflammation | 2 | 2020 | 1480 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1457 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 999 | 0.100 |
Why?
|
| Vascular System Injuries | 1 | 2013 | 57 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2011 | 237 | 0.090 |
Why?
|
| Nanoshells | 1 | 2012 | 12 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2016 | 686 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2013 | 119 | 0.090 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 294 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2013 | 175 | 0.090 |
Why?
|
| Phototherapy | 1 | 2012 | 37 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 196 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 50 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 485 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 808 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2059 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 543 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2014 | 1479 | 0.080 |
Why?
|
| Dextrans | 3 | 2009 | 42 | 0.080 |
Why?
|
| Radiotherapy, Conformal | 2 | 2008 | 49 | 0.080 |
Why?
|
| Recombinant Proteins | 5 | 2016 | 1319 | 0.080 |
Why?
|
| Camptothecin | 1 | 2010 | 76 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 589 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2010 | 23 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 28 | 0.080 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 19 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1800 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 101 | 0.080 |
Why?
|
| Glycerophosphates | 1 | 2010 | 4 | 0.080 |
Why?
|
| Anisotropy | 1 | 2010 | 117 | 0.080 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 39 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2012 | 520 | 0.080 |
Why?
|
| Fibrin | 1 | 2010 | 64 | 0.080 |
Why?
|
| Elasticity | 1 | 2010 | 97 | 0.080 |
Why?
|
| Gels | 1 | 2010 | 59 | 0.080 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2010 | 41 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 178 | 0.070 |
Why?
|
| Antibodies | 2 | 2016 | 316 | 0.070 |
Why?
|
| Macrophages | 2 | 2026 | 661 | 0.070 |
Why?
|
| Models, Animal | 2 | 2011 | 448 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 108 | 0.070 |
Why?
|
| Temperature | 1 | 2010 | 290 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 107 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2593 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2025 | 2547 | 0.070 |
Why?
|
| Female | 10 | 2026 | 70504 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2008 | 199 | 0.070 |
Why?
|
| Arterioles | 2 | 2009 | 37 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2010 | 581 | 0.070 |
Why?
|
| Receptors, Collagen | 1 | 2007 | 6 | 0.070 |
Why?
|
| Tight Junctions | 2 | 2004 | 40 | 0.060 |
Why?
|
| Capillary Permeability | 2 | 2006 | 73 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2008 | 927 | 0.060 |
Why?
|
| Mutation | 1 | 2020 | 6062 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 29 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2006 | 47 | 0.060 |
Why?
|
| Cell Wall | 1 | 2006 | 44 | 0.060 |
Why?
|
| Osteogenesis | 2 | 2021 | 182 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2020 | 849 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1366 | 0.060 |
Why?
|
| Insulin | 2 | 2024 | 1146 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2010 | 711 | 0.060 |
Why?
|
| E-Selectin | 1 | 2005 | 38 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 267 | 0.060 |
Why?
|
| P-Selectin | 1 | 2005 | 69 | 0.050 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 143 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2025 | 100 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 1276 | 0.050 |
Why?
|
| Pia Mater | 1 | 2004 | 9 | 0.050 |
Why?
|
| Spermatic Cord | 1 | 2004 | 5 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3812 | 0.050 |
Why?
|
| Rhodamines | 1 | 2004 | 22 | 0.050 |
Why?
|
| Proinsulin | 1 | 2024 | 13 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 416 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2006 | 280 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 290 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2007 | 329 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2025 | 160 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2024 | 24 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 64 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2024 | 46 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 405 | 0.050 |
Why?
|
| Glucagon | 1 | 2024 | 145 | 0.050 |
Why?
|
| Mice, SCID | 3 | 2010 | 583 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2005 | 823 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2026 | 426 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2005 | 250 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2025 | 136 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2024 | 119 | 0.050 |
Why?
|
| Base Sequence | 2 | 2007 | 2730 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2003 | 28 | 0.050 |
Why?
|
| Guanidines | 1 | 2003 | 21 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 135 | 0.050 |
Why?
|
| Gene Expression | 2 | 2007 | 1482 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2576 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2003 | 69 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 91 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 656 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 170 | 0.050 |
Why?
|
| Thrombosis | 1 | 2007 | 498 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 186 | 0.050 |
Why?
|
| Radiation, Ionizing | 3 | 2010 | 38 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 927 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 268 | 0.040 |
Why?
|
| Vasodilation | 1 | 2003 | 175 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2002 | 130 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 222 | 0.040 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 13 | 0.040 |
Why?
|
| Weight Gain | 1 | 2024 | 384 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2021 | 41 | 0.040 |
Why?
|
| Astrocytoma | 1 | 2002 | 101 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 69 | 0.040 |
Why?
|
| Infant | 3 | 2020 | 13308 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 50 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 48 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 33 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 208 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 33 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 2000 | 26 | 0.040 |
Why?
|
| Lactates | 1 | 2020 | 81 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2002 | 198 | 0.040 |
Why?
|
| Permeability | 2 | 2011 | 119 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2020 | 15036 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2026 | 759 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 340 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 1004 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 90 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 358 | 0.040 |
Why?
|
| Child | 5 | 2020 | 26243 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2010 | 33 | 0.040 |
Why?
|
| Muramidase | 2 | 2010 | 37 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 253 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2010 | 115 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 646 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 420 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2025 | 888 | 0.030 |
Why?
|
| Leukocyte Rolling | 2 | 2011 | 4 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 20873 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 59 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2006 | 0.030 |
Why?
|
| Lung | 1 | 2025 | 1535 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 514 | 0.030 |
Why?
|
| Cell Survival | 2 | 2010 | 828 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2321 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 978 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2009 | 698 | 0.030 |
Why?
|
| Progeria | 1 | 2016 | 17 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 74 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2016 | 59 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 630 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1363 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 189 | 0.030 |
Why?
|
| Adipokines | 1 | 2016 | 119 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 428 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 97 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 158 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 221 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 480 | 0.030 |
Why?
|
| Hypoxia | 2 | 2007 | 247 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 583 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 873 | 0.030 |
Why?
|
| Microspheres | 2 | 2005 | 66 | 0.030 |
Why?
|
| Blood Cells | 1 | 2013 | 53 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 252 | 0.030 |
Why?
|
| Peptides | 2 | 2007 | 707 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 148 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 319 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1592 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1912 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 254 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 57 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2393 | 0.020 |
Why?
|
| Neoplasms | 1 | 2007 | 2985 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 243 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 70 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 851 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3465 | 0.020 |
Why?
|
| Biotransformation | 1 | 2010 | 54 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 232 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 148 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2010 | 41 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 43 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2010 | 27 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 30 | 0.020 |
Why?
|
| Joints | 1 | 2010 | 25 | 0.020 |
Why?
|
| Rheology | 1 | 2010 | 24 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 50 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2010 | 23 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 144 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 85 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2010 | 31 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2010 | 59 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 99 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 121 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2009 | 164 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 112 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 246 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 411 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4662 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1783 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 483 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 576 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2007 | 23 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2007 | 34 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1014 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 39 | 0.020 |
Why?
|
| Chlorides | 1 | 2007 | 97 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 975 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2007 | 23 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2007 | 34 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 100 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 110 | 0.020 |
Why?
|
| Neurons | 2 | 2007 | 1978 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2006 | 31 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2006 | 21 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 44 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 56 | 0.020 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 210 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 600 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 229 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 10032 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 355 | 0.010 |
Why?
|
| Dependovirus | 1 | 2007 | 159 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2010 | 567 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 246 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 718 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 742 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 719 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 409 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 344 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2553 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2006 | 389 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 481 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17619 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1714 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2885 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 670 | 0.010 |
Why?
|
| Physical Phenomena | 1 | 2000 | 3 | 0.010 |
Why?
|
| Physics | 1 | 2000 | 12 | 0.010 |
Why?
|
| Hematocrit | 1 | 2000 | 104 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28392 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 687 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31098 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 741 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 141 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 371 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1813 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8622 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 6421 | 0.010 |
Why?
|